Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition

Journal of Neurochemistry

Volumn 81, Issue 3, 2002, Pages 441-448

  Fodero, Lisa R ^a   Sáez Valero, Javier ^b   McLean, Catriona A ^a   Martins, Ralph N ^c   Beyreuther, Konrad ^d   Masters, Colin L ^a   Robertson, Terry A ^c   Small, David H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

AChE; Amyloid; Glycosylation; Tg2576

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID; BIOLOGICAL MARKER; CONCANAVALIN A;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME GLYCOSYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME ACTIVATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOSYLATION; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICE; MICE, TRANSGENIC; SENILE PLAQUES;

ANIMALIA; MUS MUSCULUS;

EID: 0036312401     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00902.x     Document Type: Article

References (39)

1. Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
2. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: Selective loss of the intermediate (10S) form
3. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human nervous system.,7
4. Staging of Alzheimer's disease-related neurofibrillary changes
5. Molecular forms of acetylcholinesterase in brain, nerve and muscle: Nature, localization and dynamics
6. A new and rapid colorimetric determination of acetylcholinesterase activity
7. Enzyme histochemical studies of senile plaques
8. High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer's disease and relation to apolipoprotein E genotype
9. Agar gel-diffusion studies on the interaction of concanavalin A, a lectin isolated from Jack Bean, with polysaccharides
10. Tau and transgenic animal models
11. Age-related CNS disorders and early death in transgenic mice over-expressing Alzheimer amyloid precursor protein
12. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
13. Analysis of heterogeneous A4 peptides in cerebrospinal fluid and blood by a newly developed sensitive western blot assay
14. APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1
15. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40 and Aβ1-42(43) in Alzheimer's disease: A study in Japan
16. Processing of the Alzheimer's disease amyloid precursor protein in Pichia pastoris: Immunodetection of alpha-, beta- and gamma-secretase products
17. The molecular forms of cholinesterase and acetylcholinesterase in vertebrates
18. Molecular and cellular biology of cholinesterases
19. Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer's pathology
20. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease
21. Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles
22. Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain
23. Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
24. Amyloid β protein levels in cerebrospinal fluid are elevated in early-onset alzheimer's disease
25. Increased neuronal and glial expression of protein kinase C isoforms in the neocortex of transgenic Tg2576 mice with amyloid pathology
26. Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain
27. Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease
28. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease
29. Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease
30. The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells
31. Tricine-sodium dodecyl sulphatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
32. Intrinsic forms of acetylcholinesterase in skeletal muscle
33. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease
34. The role of acetylcholinesterase in the pathogenesis and diagnosis of Alzheimer's disease
35. Measurement of protein using bicinchoninic acid
36. Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G+C-rich attenuating structure
37. Elevated levels of tau in cerebrospinal fluid: Implications for the ante mortem diagnosis of Alzheimer's disease
38. Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability